Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    10817555 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Daclizumab to Treat Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Daclizumab
2 Completed An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
Condition: Wegener's Granulomatosis
Intervention: Drug: Rituximab

Study has passed its completion date and status has not been verified in more than two years.